Cost ManagementMargins were negatively impacted by lower-than-expected Epicel sales, increased headcount, and incremental costs related to VCEL's new manufacturing facility.
Revenue EstimatesThe company reported total revenues of $52.6M for the quarter, compared to the consensus revenue estimate of $53.8M, and a net loss of $0.23 per share, compared to the consensus estimated net loss of $0.13 per share.
Sales PerformanceVCEL reported lower-than-expected Epicel sales, which contributed to a decline in overall sales performance.